Thursday 26 January
Halaven® (eribulin) improves survival for women with locally advanced or metastatic breast cancer
|
Latest News Other newsTuesday 24 January
Tuesday 24 January
Tuesday 24 January
Tuesday 24 January
Friday 20 January
Industry News
Thursday 26 January
Halaven® (eribulin) improves survival for women with locally advanced or metastatic breast cancer
Thursday 26 January
Merck Serono receives European approval to expand use of Rebif® in patients with early multiple sclerosis
Thursday 26 January
Studies investigate drug in patients with locally advanced or recurrent/metastatic cancer
|
Roundtable
Iron sucrose complex drugs - identical or just similar?
Continuing the series of HPE Pharmacist Roundtable Meetings on complex non-biological drugs, a panel of senior European hospital pharmacists and renal specialists met in Utrecht, The Netherlands, to discuss insights and advances in the field and to consider the evidence for therapeutic differences between iron sucrose originator and iron sucrose similar preparations.
Regulation of complex molecules
Roundtable meetings in London and Paris discussed evidence for therapeutic differences between the originator iron sucrose and iron sucrose similars and called for a new regulatory pathway for non-biological complex molecules.
Supplements |